FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development

STAT's AI Prognosis takes a closer look at how the U.S. moonshot agency for health research is developing AI agents for deployment in hospitals.

A Huntington's researcher treads lightly into the UniQure-FDA fray, J&J wins approval for a first-of-its kind psoriasis pill, and more in today's Readout newsletter.

JAMA Cardiology study says premature menopause, three times more common in Black women, is a risk factor for heart disease — but scientists aren't sure why.

As the Trump administration goes after fraud in health care, advocates say the disability community feels singled out.